|
scrc attended 2nd dia china annual meeting
shanghai, may 24, 2010 - scrc attended the 2nd dia (drug information association) china annual meeting held may 16 - 19, 2010 in beijing, china. with the theme of "priming china for drug innovation and development: from strategy to execution", the meeting was aimed to serve as an international, neutral forum for attendees to collectively discuss how china can play a leadership role in drug development. nearly 100 speakers from major regulatory agencies, industry, and academia presented at the meeting, and they delivered updated information and shared their perspectives on global drug development. key sessions and topics include regulatory affairs, clinical research, pharmacovigilance, clinical data management and statistics, non-clinical safety assessment, and cmc/gmp. more than 500 professionals involved in drug research and development attended the meeting.
scrc hold a booth at the meeting, and it was the second time of scrc to attend dia china annual meeting. dr rongxing gan, the president of scrc, said "we would like to learn the updates of global drug development and exchange perspectives in research and strategic positioning in the global market through such a good platform."
both dr rongxing gan and dr juncai xu, vp of scrc are the provisional advisory council of china (pacc) members of dia. they provide support and strategic oversight for dia´s presence in china. the pacc has over 26 active members, who are from a pharma industry, regulators, sfda-ccpie, and academic background.
about dia
dia is a neutral, nonprofit, global, professional association of nearly 18,000 members who work in every facet of the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products. for more information about dia, you can visit http://www.diahome.org. |
